Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2020-08-28

AUTHORS

Amandine Pallardy, Caroline Rousseau, Catherine Labbe, Renan Liberge, Caroline Bodet-Milin, Françoise Kraeber-Bodere, Vincent Fleury

ABSTRACT

PurposeTo assess the rate and pattern of incidental interstitial lung abnormalities suggestive of COVID-19 on 18F-FDG PET/CT in asymptomatic cancer patients during the period of active COVID-19 circulation between March and April 2020 in a geographic area of low prevalence of the virus.Methods1396 18F-FDG PET/CT performed between January 1, 2020, and February 21, 2020, and between March 16, 2020, and April 17, 2020 for routine oncological indication were retrospectively analyzed. No patients had symptoms suggestive of COVID-19 at the time of the 18F-FDG PET/CT. Incidental interstitial pneumonias suggestive of COVID-19 were identified, and the 18F-FDG PET/CT patterns were described. We compared the incidence of these lesions in the pre-COVID and pandemic phases.ResultsWe observed a 1.6% increase in interstitial lung abnormalities during the period of COVID-19 circulation. All had < 50% lung involvement. We describe a case series with typical and atypical interstitial pneumonias suggestive of COVID-19 as unilateral or bilateral with ground-glass opacity, consolidation, or crazy-paving patterns.ConclusionThe relatively low increase in incidental findings suggestive of COVID-19 infection on 18F-FDG PET/CT in asymptomatic cancer patients was in accordance with the low COVID-19 transmission in our geographic region. Nevertheless, nuclear medicine physicians should familiarize themselves with typical and atypical 18F-FDG PET/CT patterns suggestive of COVID-19 pneumonia and initiate appropriate intervention where necessary. More... »

PAGES

287-292

References to SciGraph publications

  • 2020-02-22. 18F-FDG PET/CT findings of COVID-19: a series of four highly suspected cases in EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00259-020-05014-3

    DOI

    http://dx.doi.org/10.1007/s00259-020-05014-3

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1130430698

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/32860074


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Clinical Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Asymptomatic Infections", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "COVID-19", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Fluorodeoxyglucose F18", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Incidental Findings", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Lung", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Positron Emission Tomography Computed Tomography", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prevalence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Radiopharmaceuticals", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Department, University Hospital of Nantes, Nantes, France", 
              "id": "http://www.grid.ac/institutes/grid.277151.7", 
              "name": [
                "Nuclear Medicine Department, University Hospital of Nantes, Nantes, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Pallardy", 
            "givenName": "Amandine", 
            "id": "sg:person.0675243557.38", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675243557.38"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CRCINA, INSERM, CNRS, Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes, Nantes, France", 
              "id": "http://www.grid.ac/institutes/grid.4817.a", 
              "name": [
                "Nuclear Medicine Department, Institut de Canc\u00e9rologie de l\u2019Ouest Ren\u00e9 Gauducheau, Saint-Herblain, France", 
                "CRCINA, INSERM, CNRS, Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes, Nantes, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rousseau", 
            "givenName": "Caroline", 
            "id": "sg:person.01240530667.47", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Radiology, Institut de Canc\u00e9rologie de l\u2019Ouest Ren\u00e9 Gauducheau, Saint-Herblain, France", 
              "id": "http://www.grid.ac/institutes/grid.418191.4", 
              "name": [
                "Radiology, Institut de Canc\u00e9rologie de l\u2019Ouest Ren\u00e9 Gauducheau, Saint-Herblain, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Labbe", 
            "givenName": "Catherine", 
            "id": "sg:person.012660663173.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012660663173.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Radiology, University Hospital of Nantes, Nantes, France", 
              "id": "http://www.grid.ac/institutes/grid.277151.7", 
              "name": [
                "Radiology, University Hospital of Nantes, Nantes, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Liberge", 
            "givenName": "Renan", 
            "id": "sg:person.0706120224.04", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706120224.04"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CRCINA, INSERM, CNRS, Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes, Nantes, France", 
              "id": "http://www.grid.ac/institutes/grid.4817.a", 
              "name": [
                "Nuclear Medicine Department, University Hospital of Nantes, Nantes, France", 
                "CRCINA, INSERM, CNRS, Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes, Nantes, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Bodet-Milin", 
            "givenName": "Caroline", 
            "id": "sg:person.01212260416.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212260416.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "CRCINA, INSERM, CNRS, Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes, Nantes, France", 
              "id": "http://www.grid.ac/institutes/grid.4817.a", 
              "name": [
                "Nuclear Medicine Department, University Hospital of Nantes, Nantes, France", 
                "Nuclear Medicine Department, Institut de Canc\u00e9rologie de l\u2019Ouest Ren\u00e9 Gauducheau, Saint-Herblain, France", 
                "CRCINA, INSERM, CNRS, Universit\u00e9 d\u2019Angers, Universit\u00e9 de Nantes, Nantes, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kraeber-Bodere", 
            "givenName": "Fran\u00e7oise", 
            "id": "sg:person.0653324404.03", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653324404.03"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Nuclear Medicine Department, Institut de Canc\u00e9rologie de l\u2019Ouest Ren\u00e9 Gauducheau, Saint-Herblain, France", 
              "id": "http://www.grid.ac/institutes/grid.418191.4", 
              "name": [
                "Nuclear Medicine Department, Institut de Canc\u00e9rologie de l\u2019Ouest Ren\u00e9 Gauducheau, Saint-Herblain, France"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fleury", 
            "givenName": "Vincent", 
            "id": "sg:person.01356201277.28", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356201277.28"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00259-020-04734-w", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1125082539", 
              "https://doi.org/10.1007/s00259-020-04734-w"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2020-08-28", 
        "datePublishedReg": "2020-08-28", 
        "description": "PurposeTo assess the rate and pattern of incidental interstitial lung abnormalities suggestive of COVID-19 on 18F-FDG PET/CT in asymptomatic cancer patients during the period of active COVID-19 circulation between March and April 2020 in a geographic area of low prevalence of the virus.Methods1396 18F-FDG PET/CT performed between January 1, 2020, and February 21, 2020, and between March 16, 2020, and April 17, 2020 for routine oncological indication were retrospectively analyzed. No patients had symptoms suggestive of COVID-19 at the time of the 18F-FDG PET/CT. Incidental interstitial pneumonias suggestive of COVID-19 were identified, and the 18F-FDG PET/CT patterns were described. We compared the incidence of these lesions in the pre-COVID and pandemic phases.ResultsWe observed a 1.6% increase in interstitial lung abnormalities during the period of COVID-19 circulation. All had <\u200950% lung involvement. We describe a case series with typical and atypical interstitial pneumonias suggestive of COVID-19 as unilateral or bilateral with ground-glass opacity, consolidation, or crazy-paving patterns.ConclusionThe relatively low increase in incidental findings suggestive of COVID-19 infection on 18F-FDG PET/CT in asymptomatic cancer patients was in accordance with the low COVID-19 transmission in our geographic region. Nevertheless, nuclear medicine physicians should familiarize themselves with typical and atypical 18F-FDG PET/CT patterns suggestive of COVID-19 pneumonia and initiate appropriate intervention where necessary.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00259-020-05014-3", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1297401", 
            "issn": [
              "1619-7070", 
              "1619-7089"
            ], 
            "name": "European Journal of Nuclear Medicine and Molecular Imaging", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "48"
          }
        ], 
        "keywords": [
          "PET/CT", 
          "asymptomatic cancer patients", 
          "PET/CT patterns", 
          "interstitial lung abnormalities", 
          "cancer patients", 
          "COVID-19 circulation", 
          "interstitial pneumonia", 
          "CT patterns", 
          "incidental finding", 
          "lung abnormalities", 
          "COVID-19", 
          "COVID-19 pneumonia", 
          "ground-glass opacities", 
          "COVID-19 infection", 
          "low-prevalence regions", 
          "nuclear medicine physicians", 
          "atypical interstitial pneumonia", 
          "lung involvement", 
          "case series", 
          "COVID-19 transmission", 
          "oncological indications", 
          "prevalence regions", 
          "low prevalence", 
          "medicine physicians", 
          "patients", 
          "appropriate interventions", 
          "pneumonia", 
          "pandemic phase", 
          "CT", 
          "abnormalities", 
          "lower increase", 
          "geographic regions", 
          "PurposeTo", 
          "geographic areas", 
          "symptoms", 
          "lesions", 
          "infection", 
          "prevalence", 
          "incidence", 
          "findings", 
          "physicians", 
          "circulation", 
          "ResultsWe", 
          "intervention", 
          "virus", 
          "period", 
          "involvement", 
          "indications", 
          "increase", 
          "patterns", 
          "opacity", 
          "rate", 
          "transmission", 
          "region", 
          "consolidation", 
          "time", 
          "area", 
          "series", 
          "accordance", 
          "phase"
        ], 
        "name": "Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region", 
        "pagination": "287-292", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1130430698"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00259-020-05014-3"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "32860074"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00259-020-05014-3", 
          "https://app.dimensions.ai/details/publication/pub.1130430698"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-12-01T06:41", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_845.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00259-020-05014-3"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00259-020-05014-3'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00259-020-05014-3'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00259-020-05014-3'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00259-020-05014-3'


     

    This table displays all metadata directly associated to this object as RDF triples.

    235 TRIPLES      21 PREDICATES      100 URIs      91 LITERALS      21 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00259-020-05014-3 schema:about N06a872ea60de4dd69cb651b67106b53b
    2 N33f54a66935b43f09d8d678c22a1bc14
    3 N359081f569b541c98a9fad45b30fa110
    4 N4a827b9f3a0a488382008d47184e6c0b
    5 N60122afcba97446d9121b6e1f038ced2
    6 N6a1c329e0dee46a99e508e95a63b8236
    7 N73d865bf7e1848fc8ee88d2e9d3dd294
    8 N7d5abb2a16d2425a9b72495f2af6c532
    9 N8446814e82ca477db6d9d24ed95dadcf
    10 N86d90d9b18d340188ad710e11c19e7ba
    11 N8996463f565f4713a48b5d16ca3ab593
    12 Ncff1c78a8b8a498aa2fea53b29284c4d
    13 Nd00b08cbc5dc4863b3d4cf81d0d41195
    14 Nd530e80b2e0449529180a420baf78a8d
    15 anzsrc-for:11
    16 anzsrc-for:1103
    17 schema:author N99737338e73e4e92b6d289069cfefc75
    18 schema:citation sg:pub.10.1007/s00259-020-04734-w
    19 schema:datePublished 2020-08-28
    20 schema:datePublishedReg 2020-08-28
    21 schema:description PurposeTo assess the rate and pattern of incidental interstitial lung abnormalities suggestive of COVID-19 on 18F-FDG PET/CT in asymptomatic cancer patients during the period of active COVID-19 circulation between March and April 2020 in a geographic area of low prevalence of the virus.Methods1396 18F-FDG PET/CT performed between January 1, 2020, and February 21, 2020, and between March 16, 2020, and April 17, 2020 for routine oncological indication were retrospectively analyzed. No patients had symptoms suggestive of COVID-19 at the time of the 18F-FDG PET/CT. Incidental interstitial pneumonias suggestive of COVID-19 were identified, and the 18F-FDG PET/CT patterns were described. We compared the incidence of these lesions in the pre-COVID and pandemic phases.ResultsWe observed a 1.6% increase in interstitial lung abnormalities during the period of COVID-19 circulation. All had < 50% lung involvement. We describe a case series with typical and atypical interstitial pneumonias suggestive of COVID-19 as unilateral or bilateral with ground-glass opacity, consolidation, or crazy-paving patterns.ConclusionThe relatively low increase in incidental findings suggestive of COVID-19 infection on 18F-FDG PET/CT in asymptomatic cancer patients was in accordance with the low COVID-19 transmission in our geographic region. Nevertheless, nuclear medicine physicians should familiarize themselves with typical and atypical 18F-FDG PET/CT patterns suggestive of COVID-19 pneumonia and initiate appropriate intervention where necessary.
    22 schema:genre article
    23 schema:isAccessibleForFree true
    24 schema:isPartOf N8dbfa5f44d1942b99f949695e952e835
    25 Nfada0d76f2fc483eb054bfd50a0ad9e2
    26 sg:journal.1297401
    27 schema:keywords COVID-19
    28 COVID-19 circulation
    29 COVID-19 infection
    30 COVID-19 pneumonia
    31 COVID-19 transmission
    32 CT
    33 CT patterns
    34 PET/CT
    35 PET/CT patterns
    36 PurposeTo
    37 ResultsWe
    38 abnormalities
    39 accordance
    40 appropriate interventions
    41 area
    42 asymptomatic cancer patients
    43 atypical interstitial pneumonia
    44 cancer patients
    45 case series
    46 circulation
    47 consolidation
    48 findings
    49 geographic areas
    50 geographic regions
    51 ground-glass opacities
    52 incidence
    53 incidental finding
    54 increase
    55 indications
    56 infection
    57 interstitial lung abnormalities
    58 interstitial pneumonia
    59 intervention
    60 involvement
    61 lesions
    62 low prevalence
    63 low-prevalence regions
    64 lower increase
    65 lung abnormalities
    66 lung involvement
    67 medicine physicians
    68 nuclear medicine physicians
    69 oncological indications
    70 opacity
    71 pandemic phase
    72 patients
    73 patterns
    74 period
    75 phase
    76 physicians
    77 pneumonia
    78 prevalence
    79 prevalence regions
    80 rate
    81 region
    82 series
    83 symptoms
    84 time
    85 transmission
    86 virus
    87 schema:name Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region
    88 schema:pagination 287-292
    89 schema:productId N2a3d9954817044229871edc990a31f92
    90 N7cb403e4b8684d3ab64acb003fa3ab41
    91 Nea532039ade74a7b9e9e8219a3243710
    92 schema:sameAs https://app.dimensions.ai/details/publication/pub.1130430698
    93 https://doi.org/10.1007/s00259-020-05014-3
    94 schema:sdDatePublished 2022-12-01T06:41
    95 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    96 schema:sdPublisher N1b729abe219f4337b4e79f41c0816bb9
    97 schema:url https://doi.org/10.1007/s00259-020-05014-3
    98 sgo:license sg:explorer/license/
    99 sgo:sdDataset articles
    100 rdf:type schema:ScholarlyArticle
    101 N06a872ea60de4dd69cb651b67106b53b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    102 schema:name Male
    103 rdf:type schema:DefinedTerm
    104 N16dcc536344b47ff99948cd203252aea rdf:first sg:person.012660663173.13
    105 rdf:rest Nb2266ff85ba849c0ba64ab0042631e32
    106 N1b729abe219f4337b4e79f41c0816bb9 schema:name Springer Nature - SN SciGraph project
    107 rdf:type schema:Organization
    108 N2a3d9954817044229871edc990a31f92 schema:name dimensions_id
    109 schema:value pub.1130430698
    110 rdf:type schema:PropertyValue
    111 N33f54a66935b43f09d8d678c22a1bc14 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    112 schema:name Neoplasms
    113 rdf:type schema:DefinedTerm
    114 N359081f569b541c98a9fad45b30fa110 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    115 schema:name Humans
    116 rdf:type schema:DefinedTerm
    117 N4a827b9f3a0a488382008d47184e6c0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    118 schema:name Aged
    119 rdf:type schema:DefinedTerm
    120 N5aed2cfbc32f4e9ea834c0e2113be657 rdf:first sg:person.0653324404.03
    121 rdf:rest Ne81c04b3deed4b9e9fbc63a867b7c280
    122 N60122afcba97446d9121b6e1f038ced2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    123 schema:name Incidental Findings
    124 rdf:type schema:DefinedTerm
    125 N6a1c329e0dee46a99e508e95a63b8236 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    126 schema:name Radiopharmaceuticals
    127 rdf:type schema:DefinedTerm
    128 N73d865bf7e1848fc8ee88d2e9d3dd294 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Female
    130 rdf:type schema:DefinedTerm
    131 N7cb403e4b8684d3ab64acb003fa3ab41 schema:name doi
    132 schema:value 10.1007/s00259-020-05014-3
    133 rdf:type schema:PropertyValue
    134 N7d5abb2a16d2425a9b72495f2af6c532 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    135 schema:name Asymptomatic Infections
    136 rdf:type schema:DefinedTerm
    137 N8446814e82ca477db6d9d24ed95dadcf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    138 schema:name Middle Aged
    139 rdf:type schema:DefinedTerm
    140 N86d90d9b18d340188ad710e11c19e7ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    141 schema:name Positron Emission Tomography Computed Tomography
    142 rdf:type schema:DefinedTerm
    143 N8996463f565f4713a48b5d16ca3ab593 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    144 schema:name COVID-19
    145 rdf:type schema:DefinedTerm
    146 N8dbfa5f44d1942b99f949695e952e835 schema:issueNumber 1
    147 rdf:type schema:PublicationIssue
    148 N99737338e73e4e92b6d289069cfefc75 rdf:first sg:person.0675243557.38
    149 rdf:rest Naaf202364c2d4d8291c313732b95197d
    150 Naaf202364c2d4d8291c313732b95197d rdf:first sg:person.01240530667.47
    151 rdf:rest N16dcc536344b47ff99948cd203252aea
    152 Nab0e08e694c349b0ac0a9812ddacd5b2 rdf:first sg:person.01212260416.00
    153 rdf:rest N5aed2cfbc32f4e9ea834c0e2113be657
    154 Nb2266ff85ba849c0ba64ab0042631e32 rdf:first sg:person.0706120224.04
    155 rdf:rest Nab0e08e694c349b0ac0a9812ddacd5b2
    156 Ncff1c78a8b8a498aa2fea53b29284c4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    157 schema:name Lung
    158 rdf:type schema:DefinedTerm
    159 Nd00b08cbc5dc4863b3d4cf81d0d41195 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    160 schema:name Fluorodeoxyglucose F18
    161 rdf:type schema:DefinedTerm
    162 Nd530e80b2e0449529180a420baf78a8d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    163 schema:name Prevalence
    164 rdf:type schema:DefinedTerm
    165 Ne81c04b3deed4b9e9fbc63a867b7c280 rdf:first sg:person.01356201277.28
    166 rdf:rest rdf:nil
    167 Nea532039ade74a7b9e9e8219a3243710 schema:name pubmed_id
    168 schema:value 32860074
    169 rdf:type schema:PropertyValue
    170 Nfada0d76f2fc483eb054bfd50a0ad9e2 schema:volumeNumber 48
    171 rdf:type schema:PublicationVolume
    172 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    173 schema:name Medical and Health Sciences
    174 rdf:type schema:DefinedTerm
    175 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
    176 schema:name Clinical Sciences
    177 rdf:type schema:DefinedTerm
    178 sg:journal.1297401 schema:issn 1619-7070
    179 1619-7089
    180 schema:name European Journal of Nuclear Medicine and Molecular Imaging
    181 schema:publisher Springer Nature
    182 rdf:type schema:Periodical
    183 sg:person.01212260416.00 schema:affiliation grid-institutes:grid.4817.a
    184 schema:familyName Bodet-Milin
    185 schema:givenName Caroline
    186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212260416.00
    187 rdf:type schema:Person
    188 sg:person.01240530667.47 schema:affiliation grid-institutes:grid.4817.a
    189 schema:familyName Rousseau
    190 schema:givenName Caroline
    191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01240530667.47
    192 rdf:type schema:Person
    193 sg:person.012660663173.13 schema:affiliation grid-institutes:grid.418191.4
    194 schema:familyName Labbe
    195 schema:givenName Catherine
    196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012660663173.13
    197 rdf:type schema:Person
    198 sg:person.01356201277.28 schema:affiliation grid-institutes:grid.418191.4
    199 schema:familyName Fleury
    200 schema:givenName Vincent
    201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01356201277.28
    202 rdf:type schema:Person
    203 sg:person.0653324404.03 schema:affiliation grid-institutes:grid.4817.a
    204 schema:familyName Kraeber-Bodere
    205 schema:givenName Françoise
    206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0653324404.03
    207 rdf:type schema:Person
    208 sg:person.0675243557.38 schema:affiliation grid-institutes:grid.277151.7
    209 schema:familyName Pallardy
    210 schema:givenName Amandine
    211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0675243557.38
    212 rdf:type schema:Person
    213 sg:person.0706120224.04 schema:affiliation grid-institutes:grid.277151.7
    214 schema:familyName Liberge
    215 schema:givenName Renan
    216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0706120224.04
    217 rdf:type schema:Person
    218 sg:pub.10.1007/s00259-020-04734-w schema:sameAs https://app.dimensions.ai/details/publication/pub.1125082539
    219 https://doi.org/10.1007/s00259-020-04734-w
    220 rdf:type schema:CreativeWork
    221 grid-institutes:grid.277151.7 schema:alternateName Nuclear Medicine Department, University Hospital of Nantes, Nantes, France
    222 Radiology, University Hospital of Nantes, Nantes, France
    223 schema:name Nuclear Medicine Department, University Hospital of Nantes, Nantes, France
    224 Radiology, University Hospital of Nantes, Nantes, France
    225 rdf:type schema:Organization
    226 grid-institutes:grid.418191.4 schema:alternateName Nuclear Medicine Department, Institut de Cancérologie de l’Ouest René Gauducheau, Saint-Herblain, France
    227 Radiology, Institut de Cancérologie de l’Ouest René Gauducheau, Saint-Herblain, France
    228 schema:name Nuclear Medicine Department, Institut de Cancérologie de l’Ouest René Gauducheau, Saint-Herblain, France
    229 Radiology, Institut de Cancérologie de l’Ouest René Gauducheau, Saint-Herblain, France
    230 rdf:type schema:Organization
    231 grid-institutes:grid.4817.a schema:alternateName CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France
    232 schema:name CRCINA, INSERM, CNRS, Université d’Angers, Université de Nantes, Nantes, France
    233 Nuclear Medicine Department, Institut de Cancérologie de l’Ouest René Gauducheau, Saint-Herblain, France
    234 Nuclear Medicine Department, University Hospital of Nantes, Nantes, France
    235 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...